心力衰竭患者卒中病史与射血分数保留或降低的预后分析
结果显示,有卒中史的患者心血管死亡、心衰住院、卒中或心梗复合终点发生率更高(HFrEF HR 1.37,HFpEF HR 1.49),且指南推荐治疗使用不足。
要点
- 有卒中史的心衰患者心血管事件风险显著增高,HFrEF HR 1.37,HFpEF HR 1.49。
- 有卒中史患者未来卒中风险加倍,且合并房颤者30%未抗凝。
- 合并动脉疾病者29%未用他汀,HFrEF 17%和HFpEF 38%收缩压未控制。
核心结论
- 有卒中史的心衰患者后续心血管事件风险高,改善指南推荐治疗的使用可能改善预后。
主要发现
- HFrEF中有卒中史者1683例(8.3%),HFpEF中1287例(9.7%)。
- HFrEF有卒中史者复合终点发生率18.23(16.81-19.77)/100人年 vs 13.12(12.77-13.48),HR 1.37(1.26-1.49),P<0.001。
- HFpEF有卒中史者复合终点发生率14.16(12.96-15.48)/100人年 vs 9.37(9.06-9.70),HR 1.49(1.36-1.64),P<0.001。
- 有卒中史患者未来卒中风险加倍,复合终点各组分均更常见。
- 有卒中史者中,合并房颤30%未抗凝,合并动脉疾病29%未用他汀,HFrEF 17%和HFpEF 38%收缩压≥140 mmHg。
临床怎么用
- 对有卒中史的心衰患者应强化指南推荐治疗,包括抗凝、他汀和血压控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Stroke is an important problem in patients with heart failure (HF), but the intersection between the two conditions is poorly studied across the range of ejection fraction. The prevalence of history of stroke and related outcomes were investigated in patients with HF. METHODS AND RESULTS: Individual patient meta-analysis of seven clinical trials enrolling patients with HF with reduced (HFrEF) and preserved ejection fraction (HFpEF). Of the 20 159 patients with HFrEF, 1683 (8.3%) had a history of stroke, and of the 13 252 patients with HFpEF, 1287 (9.7%) had a history of stroke. Regardless of ejection fraction, patients with a history of stroke had more vascular comorbidity and worse HF. Among those with HFrEF, the incidence of the composite of cardiovascular death, HF hospitalization, stroke, or myocardial infarction was 18.23 (16.81-19.77) per 100 person-years in those with prior stroke vs. 13.12 (12.77-13.48) in those without [hazard ratio 1.37 (1.26-1.49), P < 0.001]. The corresponding rates in patients with HFpEF were 14.16 (12.96-15.48) and 9.37 (9.06-9.70) [hazard ratio 1.49 (1.36-1.64), P < 0.001]. Each component of the composite was more frequent in patients with stroke history, and the risk of future stroke was doubled in patients with prior stroke. Among patients with prior stroke, 30% with concomitant atrial fibrillation were not anticoagulated, and 29% with arterial disease were not taking statins; 17% with HFrEF and 38% with HFpEF had uncontrolled systolic blood pressure (≥140 mmHg). CONCLUSION: Heart failure patients with a history of stroke are at high risk of subsequent cardiovascular events, and targeting underutilization of guideline-recommended treatments might be a way to improve outcomes in this high-risk population.
引用
- Yang, Kondo, Butt, et al. Stroke in patients with heart failure and reduced or preserved ejection fraction. Eur Heart J. 2023. PMID: 37358785. doi:10.1093/eurheartj/ehad338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。